Immunoassay instrument is gaining rapid adoption in the gene-based analysis especially for oncology
Immunoassays, or DNA assays, are a method of
DNA analysis. DNA is the basis of all biological material, including the DNA of
living organisms, cells, and tissues. This method can be used to analyze,
identify, and profile various biological samples. The analysis of DNA has
developed greatly over the years, due to the ability to conduct DNA tests on
living people.
The use of immunoassays for gene-based analysis
has grown tremendously. Primarily, immunoassay analysis is used to evaluate
gene-based treatments in oncology, cardiovascular, orthopedics, infectious
diseases, and clinical diagnostics. Currently, the primary uses of immunoassays
are for the evaluation of gene-based therapies in oncology and cardiovascular
clinical trials.
The analysis and measurement of immune
parameters by immunoassay
instruments are known as response curve analysis (RCA). The first analysis
of RCA was done by Ward and coworkers in 1980, using monoclonal antibodies to
stimulate the lymphocytes Subsequent immunoassay measurement models and systems
have been developed to extend the scope of research and to make immunoassay
measurement more cost-effective. As part of the global research effort on the
future of Immunoassay Instruments.
There are other uses for immunoassays other
than the medical diagnosis and staging of infectious diseases. In the
pharmaceutical and bio-medical industries, these instruments are often used for
the direct quantification and analysis of the efficiency and toxicity of
therapeutic drugs in clinical trials and/or manufacturing processes. In
addition, immunoassay systems are also used in the Food and Drug Administration
(FDA) to determine the concentration of contaminants in manufactured
pharmaceuticals. And sometimes, they are used to test the effects of new drugs
on humans when they are administered in patients with preexisting disease.
Comments
Post a Comment